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Objective: To provide a systematic overview of the effects of various parame-
ters on contrast enhancement within the same population, an animal experiment
as well as a computer-aided simulation study was performed.
Materials and Methods: In an animal experiment, single-level dynamic CT
through the liver was performed at 5-second intervals just after the injection of
contrast medium for 3 minutes. Combinations of three different amounts (1, 2, 3
mL/kg), concentrations (150, 200, 300 mgI/mL), and injection rates (0.5, 1, 2
mL/sec) were used. The CT number of the aorta (A), portal vein (P) and liver (L)
was measured in each image, and time-attenuation curves for A, P and L were
thus obtained. The degree of maximum enhancement (Imax) and time to reach
peak enhancement (Tmax) of A, P and L were determined, and times to equilibri-
um (Teq) were analyzed. In the computed-aided simulation model, a program
based on the amount, flow, and diffusion coefficient of body fluid in various com-
partments of the human body was designed. The input variables were the concen-
trations, volumes and injection rates of the contrast media used. The program
generated the time-attenuation curves of A, P and L, as well as liver-to-hepatocel-
lular carcinoma (HCC) contrast curves. On each curve, we calculated and plotted
the optimal temporal window (time period above the lower threshold, which in this
experiment was 10 Hounsfield units), the total area under the curve above the
lower threshold, and the area within the optimal range.
Results: A. Animal Experiment: At a given concentration and injection rate, an
increased volume of contrast medium led to increases in Imax A, P and L. In addi-
tion, Tmax A, P, L and Teq were prolonged in parallel with increases in injection
time The time-attenuation curve shifted upward and to the right. For a given volume
and injection rate, an increased concentration of contrast medium increased the
degree of aortic, portal and hepatic enhancement, though Tmax A, P and L
remained the same. The time-attenuation curve shifted upward. For a given volume
and concentration of contrast medium, changes in the injection rate had a promi-
nent effect on aortic enhancement, and that of the portal vein and hepatic
parenchyma also showed some increase, though the effect was less prominent. A
increased in the rate of contrast injection led to shifting of the time enhancement
curve to the left and upward. B. Computer Simulation: At a faster injection rate,
there was minimal change in the degree of hepatic attenuation, though the duration
of the optimal temporal window decreased. The area between 10 and 30 HU was
greatest when contrast media was delivered at a rate of 2 3 mL/sec. Although the
total area under the curve increased in proportion to the injection rate, most of this
increase was above the upper threshould and thus the temporal window was nar-
row and the optimal area decreased. 
Conclusion: Increases in volume, concentration and injection rate all resulted in
improved arterial enhancement. If cost was disregarded, increasing the injection
volume was the most reliable way of obtaining good quality enhancement. The opti-
mal way of delivering a given amount of contrast medium can be calculated using a
computer-based mathematical model. o provide better anatomic detail and charac-
terization of the pathology observed, intra-
venous contrast medium routinely used in ab-
dominal computed tomography (CT). Although it has been
generally agreed that rapid injection of a large amount of
contrast medium can lead to improved enhancement of
vascular structures, the optimal method of delivering a giv-
en amount of iodine in terms of the concentration, volume
and injection rate of the medium is still a matter of contro-
versy. A large amount of contrast medium can provide bet-
ter organ enhancement, but the cost is greater and there is
possible renal toxicity. Fast injection offers improved arter-
ial enhancement, though organ enhancement may be sub-
optimal and the temporal window is narrow. 
During the past few years, investigators have compared
the effect of various volumes and injection rates of contrast
medium on aortic and hepatic enhancement. These clinical
studies compared different techniques within different pop-
ulations, however, and the published results are controver-
sial (1-6). Furthermore, most studies were performed in a
clinical setting and thus only data from a limited portion of
time-attenuation curves were analyzed. Although these
previous studies have provided certain empirical informa-
tion, a systemic approach to understanding the effects of
various parameters on contrast enhancement within the
same population is, as far as we know, lacking.
The purpose of this article is to illustrate the effect of
various concentrations, volumes and injection rates of con-
trast media on aortic, portal venous and hepatic enhance-
ment obtained (a) during animal experiments involving se-
rial single-level dynamic CT of the liver (eight dogs), and
(b) with the aid of a computer-aided simulated model. In
addition, the considerations involved in deciding optimal
scan delay for the arterial and portal venous phase are dis-
cussed. 
MATERIALS AND METHODS
A. Animal Experiment
In eight dogs, single-level dynamic CT (GE Hi-speed
Advantage System; Milwaukee, Wis., U.S.A.) through the
liver was performed at 5-second intervals just after the in-
jection of contrast medium for 3 minutes (120 kV, 210
mA, 10-mm slice thickness). Combinations of three differ-
ent amounts (1, 2, 3 mL/kg), concentrations (150, 200, 300
mgI/mL) and injection rates (0.5, 1, 2 mL/sec) were used,
and thus a total of 27 injection protocols (Table 1). These
data are subsets of the authors’ published data (7), and
identical methods were used.
The CT number of the aorta (A), portal vein (P) and liver
(L) was measured in each image, and from those 216 sets
of data, time-attenuation curves of A, P and L were ob-
tained. To compensate for individual variations in circula-
tion time, the start of aortic enhancement (the point at
which aortic attenuation began to rise above the baseline)
was set to “zero time” in each set of data. Data from the
same injection protocol were pooled, and for each proto-
col, a single time-attenuation curve was generated.
The degree of maximum enhancement (Imax) and time
to reach peak enhancement (Tmax) of A, P and L were de-
termined, and times to equilibrium (Teq) were analyzed.
Time to equilibrium was defined according to a theoretical
model proposed by Foley (8) in which the equilibrium
phase occurs when the aortic and hepatic contrast enhance-
ment curves become parallel and begin to decline at a simi-
lar rate. To determine quantitatively the onset of paral-
lelism of the aortic and hepatic enhancement curves, the
method of least squares was used to fit a single knot point
to the linear splines of these differences as a function of
time. The knot point represented the point at which the
difference between the aortic and hepatic enhancement be-
came constant (i.e. the slope to the right of the knot point
was zero). The knot point was therefore taken to represent
the time of onset of equilibrium.
B. Computer Model
On the basis of the compartment model proposed by Bae
et al.(9) (Fig. 1), a computer simulation program was de-
signed (10). The input variables were the concentrations,
volumes and injection ratesof the contrast media used, and
from these the simulated time-attenuation curve of A, P
and L, as well as the liver-to-hepatocellular carcinoma
(HCC) contrast curve were generated. Using the simulated
model, we calculated the attenuation difference between
an HCC and the liver (Fig. 2). On simulated curves, we ar-
bitrarily set 10 HU as the minimum CT attenuation differ-
ence for the detection of a hypervascular mass. If the dif-
ference between this mass and the liver is less than 10 HU,
a lesion may not be detected, while a level of more than 20
or 30 HU is higher than that required to detect a lesion and
therefore superfluous. On each curve, we calculated and
plotted the optimal temporal window (time period above
the lower threshold), total area under the curve above the
lower threshold, and the area within the optimal range
(Fig. 3).
RESULTS
A. Animal Experiment
a) Volume of Contrast Media
For a given concentration and injection rate, an increased
volume of contrast medium led to increases in Imax A, P
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Tand L. In addition, Tmax A, P, L and Teq were prolonged
in parallel with increases in injection time (Fig. 4). An in-
creased volume of contrast medium led to shifting of the
time-attenuation curve upward and to the right.
b) Concentration of Contrast Media
For a given volume and injection rate, an increased in
the concentration of the contrast medium increased the de-
gree of aortic, portal and hepatic enhancement, though
Tmax A, P and L remained the same. After increasing the
concentration of contrast medium, the time-attenuation
curve was thus seen to shift upward (Fig. 5).
c) Injection Rate of Contrast Media
For a given volume and concentration of contrast media,
changes in the injection rate had a prominent effect on aor-
tic enhancement. The portal vein and hepatic parenchyma
also showed a degree of enhancement, though this was less
prominent. An increased rate of contrast medium injection
led to shifting of the time-enhancement curve upward and
to the left (Fig. 6).
d) Delivery Mode of a given amount of Iodine
For a given amount of iodine, either a high concentration
and small volume, or a low concentration and large vol-
ume can be chosen. At the same injection rate, the combi-
nation of large volume-low concentration contrast medium
produced better hepatic and vascular enhancement than
did small volume-high concentration (Fig. 7). Using a large
Han et al.
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Table 1. Contrast Injection Protocols Used in This Study
Concentration (mgI/mL) Amount (mL/kg) Rate (mL/sec) Concentration (mgI/mL) Amount (mL/kg) Rate (mL/sec)
150 0.5 0.5 200 1 0.5
150 0.5 1 200 1 1
150 0.5 2 200 1 2
150 1 0.5 200 2 0.5
150 1 1 200 2 1
150 1 2 200 2 2
150 2 0.5 300 0.5 0.5
150 2 1 300 0.5 1
150 2 2 300 0.5 2
200 0.5 0.5 300 1 0.5
200 0.5 1 300 1 1
200 0.5 2 300 1 2
300 2 0.5
300 2 1
300 2 2
Fig. 1. Compartment model to illustrate
the transport process of contrast medium
to the liver. 
Blood is supplied to the liver by both the
hepatic artery (HA) and portal vein (vein
1), but the HCC compartment is supplied
exclusively by the hepatic artery. (Partial
adoptation and modification of the model
proposed by Bae (9); V: volume of the
compartment, Q: flow rate).
Capillaries of
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V=35
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part of the aorta
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Q=455
mL/min
Q=495mL/min
Q=935mL/min Q=935mL/min
Q=1430mL/minamount of contrast medium, the time taken to reach peak
enhancement of both the vascular structure and the liver
increased with duration of injection (graphs shifted upward
and to the right.) To take advantage of the low concentra-
tion-large volume scenario, scan delay time must be adjust-
ed.
B. Computer Simulation
a) Correlation with actual experimental data
Our simulation program generated time-attenuation
curves which correlated well with actual experimental data
(Fig. 8). At a faster injection rate, there was minimal
change in the degree of hepatic attenuation, as shown in
Fig. 6.
b) Plotting of Optimal Temporal Window 
Twenty-five methods of delivering 45 g of iodine (con-
centration range 200 360 mgI/mL, volume 125 225 mL,
injection rate 1 5 mL/sec) were tested. Optimal temporal
window duration decreased as the injection rate increased
(Fig. 9). However, if injection of the medium was slow and
its concentration very low, enhancement was too poor to
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Fig. 4. Time-attenuation curves obtained at an identical injection rate (1 mL/sec) and concentration (300mgl/mL) of contrast medium, but
with different volumes [1 (n=8), 2 (n=6), 3 (n=6) mL/kg, respectively].
A. Time-attenuation curves for the aorta and portal vein show that an increased injection volume leads to increased enhancement, and
an increased duration of injection leads to a shifting of Tmax to the right (arrow).
B. Time-attenuation curves for hepatic parenchyma show the same changes as in (A).
AB
Fig. 2. Time-attenuation curves generated from our program.
From the time-attenuation curves for hepatic parenchyma and
simulated hepatocellular carcinoma, the HCC-to-liver contrast
curve, representing tumor visibility, could be generated.
Fig. 3. HCC-to-liver contrast plotted against time. 
The graph represents the CT attenuation difference between nor-
mal hepatic parenchyma and HCC. The shaded area between
the lower (red line) and upper threshold (blue line) represents op-
timal enhancement. The area below 10 HU (*) is suboptimal and
above 20 HU (arrow) is superfluous. The shaded area plus su-
perfluous enhancement is represented by the total area under the
curve above the lower threshold.
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c) Plotting of Optimal Enhancement
For a given HCC-liver contrast curve, the integral area of
a curve between 10 and 20 (or 30) HU represented both
the duration of the temporal window and the optimal con-
trast. The area between 10 and 20 HU was greater than
700 when using low-concentration contrast medium (< 300
mgI/mL) administered at 2 mL/sec; that between 10 and
30 HU was greatest when delivering contrast medium at a
rate of 2 3 mL/sec (Fig.10). Although the total area under
the curve increased in proportion to the injection rate, this
increase occurred mainly above the upper threshold, and
thus the temporal window was narrow and the optimal
area decreased (Fig. 11).
DISCUSSION
Intravenous contrast medium is a fundamental part of
abdominal CT and CT angiography. If properly adminis-
tered, contrast medium enhances normal tissues and vascu-
lar structures to a degree greater than that seen with most
infectious and neoplastic processes. In some types of hy-
Han et al.
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Fig. 5. Time-attenuation curves obtained at an identical injection rate (1 mL/sec) and volume (2 mL/kg)of contrast medium, but at differ-
ent concentrations [150, 200, 300 mgI/mL, respectively (n=7 in all three groups)].
A. Time-attenuation curves for the aorta vein show that an increased concentration of contrast medium leads to increases in the degree
of enhancement, but since the duration of injection has not changed, Tmax is the same (arrow). 
B. Time-attenuation curves for hepatic parenchyma shows the same changes as in (A).
AB
Fig. 6. Time-attenuation curves obtained at an identical concentration (300 mgI/mL) and volume (3mL/kg) of contrast medium, but at dif-
ferent injection rates [0.5 (n=8), 1 (n=6), 2 (n=7) mL/sec, respectively].
A. Time-attenuation curves for the aorta show that with an increased injection rate the degree of enhancement increases, but since the
duration of injection is shortened, Tmax decreases (arrow).
B. Time-attenuation curves for the liver show the same changes as in (A). However, the degree of maximal liver enhancement at injec-
tion rates of 1 and 2 mL/sec is almost the same, while Tmax has shifted to the left. 
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Fig. 8. Simulated time-attenuation curves generated by computer
program. When volume, concentration and injection rates were
changed, close correlation with actual experimental data was ob-
served.
A. Volume of contrast medium was increased from 130 to 250 mL,
while the injection rate and concentration remained at 3 mL/sec
and 300 mgI/mL, respectively.
B. Concentration was increased from 200 to 400 mgI/mL, while the
volume and injection rate remained at 150 mL and 3 mL/sec, re-
spectively.
C. Injection rate was increased from 2 to 5.5 mL/sec, while the vol-
ume and concentration remained at 150 mL and 300 mgl/mL, re-
spectively. 
AB
C
Fig. 7. Comparison of two time-attenuation curves obtained while injecting identical amounts of iodine (600 mgI/kg) at different rates [1
mL/sec (A), and 2 mL/sec (B)].
A. At 1mL/sec, the degree of aortic enhancement is almost the same. Contrast medium in a low concentration-large volume combination
(n=8) produced better portal and hepatic enhancement than a high concentration-small volume combination (n=6).
B. At 2mL/sec, a low concentration-large volume combination (n=7) produced better aortic, portal and hepatic enhancement than a high
concentration-small volume combination (n=7).
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)pervascular tumor, tumor mass enhances during the early
‘arterial’ phase before normal surrounding parenchyma is
adequately enhanced.
If spiral CT is used, multi-phase CT after a single injec-
tion of contrast medium is possible; discussion of the opti-
mal method for delivery of the medium has involved heat-
ed controversy, however. Chambers et al. (11, 12) report-
ed that an increased volume of contrast medium resulted in
better hepatic enhancement and a wider temporal window
(i.e. increased Tmax and Teq), while an increased injection
rate gave rise to greater hepatic enhancement and a nar-
rower temporal window. With faster injection of a smaller
volume, the degree of hepatic enhancement partially com-
pensated for the decreased volume. Garcia et al. (6) report-
ed, however, that a higher injection rate led to narrowing
of the temporal window, while the effect on the hepatic
parenchyma was minimal because the bolus effect was lost
in the mesenteric circulation. In clinical practice, images of
the liver and vascular structures are obtained only during
the limited temporal window (20 40 and 60 80 secs, for
example). The true dynamics of contrast media is thus not
well understood. 
With our single-level dynamic CT animal model, it was
possible to understand the dynamics of contrast media and
the effect of varying the amount, injection rate and con-
centration on enhancement of the aorta, portal circulation
and hepatic parenchyma. As the results demonstrated, the
effects of increased amounts (total iodine load and dura-
tion of injection) of contrast media were most pronounced
with regard to enhancement of the portal vein and hepatic
parenchyma. Tmax and Teq were also prolonged, and a
wider temporal window was thus possible. In view of the
great variation in individual circulation time, this wide
temporal window provides a greater likelihood of satisfac-
tory enhancement. The penalty for increased volume is
cost and possible systemic toxicity.
Increased concentration (total iodine load only) strongly
affected aortic enhancement, though the effect was less in
the portal vein and hepatic parenchyma. Tmax and Teq
were the same, and with increased concentration there was
thus neither gain  nor loss in terms of temporal window, a
small gain in hepatic enhancement, but increased cost and
Han et al.
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Fig. 9. Using high-concentration medium, the width of the tempo-
ral window decreases as the injection rate is increased or the vol-
ume is decreased. 
However, when low-concentration medium (200 mgl/mL) is deliv-
ered very slowly (1 mL/sec), enhancement will not be satisfactory.
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Fig.10. Area under the curve and area
between the lower and upper threshold
calculated at various injection rates.
A. 45g Iodine in 125 mL of contrast
medium (360 mgI/mL). At a faster injec-
tion rate, the total area under the curve
increases. The area between the two
threshold values peaks at an injection
rate of 2 mL/sec, however.
B. 45 g Iodine in 167 mL of contrast
medium (270 mgI/mL). The graph
shows the same tendency as (A), while
the peak is observed at an injection rate
of 2 to 3 mL/sec, depending on the
threshold value.
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Delivery of the same amount of contrast medium at a
faster injection rate resulted in a shorter duration of injec-
tion, while a faster injection rate led to higher arterial en-
hancement. 
In the portal vein and hepatic parenchyma, however, the
effect of bolus injection gradually diminished. Among the
three factors tested in our experiment, an increased injec-
tion rate alone exerted least effect on the enhancement of
the portal venous system and hepatic parenchyma.
Possible explanations for this weak influence on hepatic
parenchyma are 1) the dilution effect described by Garcia
et al. (6), and 2) the possibility that a certain time might be
needed for the contrast medium to leak into the intersti-
tium of the liver. Shorter exposure to a more highly con-
centratel portal flow might induce less hepatic enhance-
ment than longer exposure to a lower concentration. A
shorter duration of injection at a faster rate resulted in
shifting of the time-attenuation curve to the left, and signif-
icantly shortened the temporal window. An increased in-
jection rate therefore involves the penalty of a narrowed
temporal window (more chance of obtaining unsatisfactory
enhancement due to individual variation without the help
of the bolus tracking method) and the possible local com-
plication of extravasation, as well as no change in cost and
little gain in hepatic enhancement. 
It is not known whether the prolonged injection of an in-
creased volume leads to better detection of hypovascular
hepatic lesion through increased enhancement of hepatic
parenchyma, or reduces detection because delayed en-
hancement of the tumor interstitium lessens the attenua-
tion difference between the tumor and hepatic parenchy-
ma. In our experiment, changing the volume of contrast
medium led to a continuous increase in attenuation of vas-
cular structure as long as injection continued, and the redis-
tribution process began only after injection had stopped.
We therefore believe that even when the arterial, portal
and interstitial components are mixed late in the injection
period, contrast between the lesion and background tissue
might be sufficient.
Our results also show that the so-called ‘arterial’ and
‘portal’ phase are determined not by a certain fixed time or
circulation time, but by the total amount of contrast medi-
um and injection rate. When designing a CT protocol, that
for the injection of contrast medium should therefore be
considered an integral part of the overall procedure.
The dynamics of contrast media in the body is complex,
and in addition, measuring the attenuation of vascular
structures as well as the liver using dynamic CT is a time-
consuming procedure. Using the mathematical model pro-
posed by Bae et al. (9), we built a simple computer pro-
gram to test the effect of various injection protocols on the
enhancement of organs (10). Although many parameters
used to build a mathematical model in humans are differ-
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Fig. 11. Comparison of area under the curve and area between the thresholds in two injection protocols (270mgI/mL and 167mL, deliv-
ered at 4 and 3 mL/sec).
A. At a rate of 4 mL/sec, the duration of the temporal window is 72.4 sec. Thet total area under the curve is 1218, while the area between
the upper and lower thresholds (30 and 10 HU, respectively, in this graph) is 996.
B. At a rate of 3 mL/sec, the duration of the temporal window is 79.1 sec. The total area under the curve is 1134 and the area between
the thresholds is 1050. Compared with (A), there is a wider temporal window and a larger area between the thresholds. At a faster injec-
tion rate, a larger area is seen under the curve, but the area of greatest increase is above the threshold (black area). 
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ent from those in an experimental canine model, the gener-
al shape of the curves is similar, as are changes in the shape
of these curves according to variations in the parameters
employed.
To detect a lesion within the liver, a certain degree of at-
tenuation difference is required; if this is insufficient, the
lesion cannot be detected. On the other hand, “too much
difference” between the liver and the pathologic lesion is
undesirable since this requires more contrast medium, and
cost and systemic toxicity both increase. In this study, we
arbitrarily set the lower and upper threshold needed for
the detection of a pathologic lesion as 10 and 30 HU, re-
spectively. 
In our mathematical model, ‘the area under the curve’ in
Figures 10 and 11 increases as a faster injection rate is
used, while the duration of the optimal temporal window
decreases. The ‘area of optimal enhancement’ - that be-
tween the lower and upper threshold - was greatest, how-
ever, at a rate of 2 to 3 mL/sec. This means that at a higher
injection rate, it may be possible to detect a more conspicu-
ous hypervascular mass while the temporal window is very
narrow. In view of the great variations in individual circu-
lation time, the part of the liver containing the tumor might
thus not be imaged at the appropriate time. Although at-
tenuation at the optimal injection rate may not be strong,
the attenuation difference will, nonetheless, be sufficient
for the lesion to be detected. Since the optimal temporal
window is wider, there is more chance of imaging the le-
sion at the appropriate time. Our data suggest that the cur-
rent technique of fast injection (4 5 mL/sec) might not pro-
duce adequate liver-to-tumor contrast or hepatic enhance-
ment. Because of individual variation in circulation time,
slower injection (2 3 mL/sec) of a large amount of contrast
medium (longer injection period) and an optimized CT
protocol might be a more effective method of obtaining
good-quality abdominal CT images.
In summary, increases in volume, concentration and in-
jection rate all resulted in improved arterial enhancement.
For the portal vein and hepatic parenchyma, however, in-
creased volume (increase in iodine load and duration of in-
jection) had the most pronounced effect, followed by in-
creased concentration. If cost was disregarded, increasing
the injection volume was the most reliable was of obtain-
ing good quality enhancement . The optimal way of deliv-
ering a given amount of contrast media can be calculated
using a computer-based mathematical model. Before de-
signing a CT protocol, a thorough understanding of the
pharmacodynamics of contrast medium in the body is es-
sential.
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